MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
121.51%
Quick Ratio
121.51%
Cash Ratio
116.58%
Debt to Asset Ratio
82.30%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Prepaid expenses and other curre...
Prepaid research and development
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Non-refundable sublicense and tr...
Accounts payable
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
24,155
33,336
46,303
52,773
Prepaid expenses and other current assets
768
682
629
1,637
Prepaid research and development
252
723
830
1,320
Total current assets
25,175
34,741
47,762
55,730
Property and equipment, net
-
826
4,107
5,159
Right of use assets - operating leases
-
651
10,168
13,001
Other assets
-
244
244
270
Total assets
25,175
36,462
62,281
74,160
Accounts payable
902
1,310
1,113
952
Accrued expenses and other current liabilities
3,567
3,895
4,653
4,001
Non-refundable sublicense and transition services payments
16,250
13,750
13,750
13,750
Operating lease liabilities
-
1,149
3,567
3,542
Total current liabilities
20,719
20,104
23,083
22,245
Operating lease liabilities - noncurrent
-
4,606
20,443
20,795
Total liabilities
20,719
24,710
43,526
43,040
Additional paid-in capital
724,593
724,068
723,512
722,894
Accumulated deficit
-720,137
-712,316
-704,757
-691,774
Total stockholders' equity
4,456
11,752
18,755
31,120
Total liabilities and stockholders' equity
25,175
36,462
62,281
74,160
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$24,155K
(-58.08%↓ Y/Y)
Prepaid expenses and
other current assets
$768K
(-45.22%↓ Y/Y)
Prepaid research and
development
$252K
(-80.42%↓ Y/Y)
Total current assets
$25,175K
(-58.26%↓ Y/Y)
Total assets
$25,175K
(-68.21%↓ Y/Y)
Total liabilities and
stockholders' equity
$25,175K
(-68.21%↓ Y/Y)
Total liabilities
$20,719K
(-49.39%↓ Y/Y)
Total stockholders'
equity
$4,456K
(-88.35%↓ Y/Y)
Accumulated deficit
-$720,137K
(-5.28%↓ Y/Y)
Total current
liabilities
$20,719K
(4.64%↑ Y/Y)
Additional paid-in capital
$724,593K
(0.32%↑ Y/Y)
Non-refundable sublicense and
transition services...
$16,250K
(66.82%↑ Y/Y)
Accrued expenses and
other current...
$3,567K
(-12.42%↓ Y/Y)
Accounts payable
$902K
(-62.34%↓ Y/Y)
Buy us a coffee
Passage BIO, Inc. (PASG)
Passage BIO, Inc. (PASG)